BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer [NanoString_IMM]
Ontology highlight
ABSTRACT: BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer [NanoString_IMM]
PROVIDER: PRJNA820857 | ENA |
REPOSITORIES: ENA
ACCESS DATA